Hypoxia induces late preconditioning in the rat heart in vivo

Anesthesiology

Volumn 113, Issue 6, 2010, Pages 1351-1360

  Berger, Marc M ^a   Huhn, Ragnar ^b   Oei, Gezina T ^c   Heinen, André ^b   Winzer, Andreas ^a   Bauer, Inge ^b   Preckel, Benedikt ^c   Weber, Nina C ^d   Schlack, Wolfgang ^c   Hollmann, Markus W ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c University Hospital of Duesseldorf ^*  (Canada)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN C; HEME OXYGENASE 1; KETAMINE; PROPOFOL; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON; SEVOFLURANE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; STAINING; UPREGULATION; WESTERN BLOTTING;

EID: 78650171964     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181fce7ea     Document Type: Article

References (44)

1. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-42
2. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Toma-selli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Ma-soudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, American Heart Association Strategic Planning Task Force and Statistics Committee: Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586-613
3. Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L, Thomas JM: The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118:504-10
4. Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM: Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268:233-9
5. McFalls EO, Ward HB, Santilli S, Scheftel M, Chesler E, Doliszny KM: The influence of perioperative myocardial infarction on long-term prognosis following elective vascular surgery. Chest 1998; 113:681-6
6. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-36
7. Bolli R: The late phase of preconditioning. Circ Res 2000; 87:972-83
8. Ferdinandy P, Schulz R, Baxter GF: Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59:418-58
9. Weber NC, Frassdorf J, Ratajczak C, Grueber Y, Schlack W, Hollmann MW, Preckel B: Xenon induces late cardiac preconditioning in vivo: A role for cyclooxygenase 2? Anesth Analg 2008; 107:1807-13
10. Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005; 94:159-65
11. Beguin PC, Joyeux-Faure M, Godin-Ribuot D, Levy P, Ribuot C: Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 2005; 99: 1064-9
12. Xi L, Tekin D, Gursoy E, Salloum F, Levasseur JE, Kukreja RC: Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol 2002; 283:H5-12
13. Beguin PC, Belaidi E, Godin-Ribuot D, Levy P, Ribuot C: Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2. J Mol Cell Cardiol 2007; 42:343-51
14. Hassouna A, Matata BM, Galinanes M: PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 2004; 287:C1418-25
15. Kitakaze M, Funaya H, Minamino T, Node K, Sato H, Ueda Y, Okuyama Y, Kuzuya T, Hori M, Yoshida K: Role of protein kinase C-alpha in activation of ecto-5'-nucleotidase in the preconditioned canine myocardium. Biochem Bio-phys Res Commun 1997; 239:171-5
16. Page EL, Robitaille GA, Pouyssegur J, Richard DE: Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002; 277: 48403-9
17. Thirunavukkarasu M, Juhasz B, Zhan L, Menon VP, Tosaki A, Otani H, Maulik N: VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Free Radic Biol Med 2007; 42:1487-95
18. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, So-lovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA: Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89:168-73
19. Toma O, Weber NC, Wolter JI, Obal D, Preckel B, Schlack W: Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. ANESTHESIOLOGY 2004; 101:1372-80
20. Obal D, Preckel B, Scharbatke H, Mullenheim J, Hoterkes F, Thamer V, Schlack W: One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87:905-11
21. Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW: Helium-induced preconditioning in young and old rat heart: Impact of mitochondrial Ca(2+)-sensitive potassium channel activation. ANESTHESIOLOGY 2008; 109:830-6
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75
23. Bolli R: Preconditioning: A paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 2007; 292:H19-27
24. Alkhulaifi AM, Yellon DM, Pugsley WB: Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg 1994; 8:270-5
25. De Hert SG, Preckel B, Hollmann MW, Schlack WS: Drugs mediating myocardial protection. Eur J Anaesthesiol 2009; 26:985-95
26. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP, Paola D, Pronzato MA, Albano E: Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33:131-9
27. Wacker BK, Park TS, Gidday JM: Hypoxic preconditioning-induced cerebral ischemic tolerance: Role of microvascu-lar sphingosine kinase 2. Stroke 2009; 40:3342-8
28. Yeh CH, Hsu SP, Yang CC, Chien CT, Wang NP: Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci 2010; 86:115-23
29. Müllenheim J, Ebel D, Bauer M, Otto F, Heinen A, Fr̈assdorf J, Preckel B, Schlack W: Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. ANESTHESIOLOGY 2003; 99:624-31
30. Bein B, Renner J, Caliebe D, Hanss R, Bauer M, Fraund S, Scholz J: The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: Comparison with continuous propofol. Anaesthesia 2008; 63:1046-55
31. Müllenheim J, Schlack W, Frässdorf J, Heinen A, Preckel B, Tḧamer V: Additive protective effects of late and early ischaemic preconditioning are mediated by the opening of KATP channels in vivo. Pflugers Arch 2001; 442:178-87
32. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ: Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. ANESTHESIOLOGY 2009; 111:267-74
33. Gray MO, Karliner JS, Mochly-Rosen D: A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997; 272:30945-51
34. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R: Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest 1998; 101:2182-98
35. Keenan C, Goode N, Pears C: Isoform specificity of activators and inhibitors of protein kinase C gamma and delta. FEBS Lett 1997; 415:101-8
36. Bogoyevitch MA, Parker PJ, Sugden PH: Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothe-lin. Circ Res 1993; 72:757-67
37. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R: Ischemic preconditioning induces selective trans-location of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997; 81:404-14
38. Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, Takano H, Balafanova Z, Bolli R: Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 1999; 85:542-50
39. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyama T, Hashimoto T, Dohi K: Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovas-cularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 2001; 88:696-704
40. Ryter SW, Alam J, Choi AM: Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006; 86:583-650
41. Semenza GL: Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 2000; 106:809-12
42. Lee SS, Gao W, Mazzola S, Thomas MN, Csizmadia E, Otterbein LE, Bach FH, Wang H: Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 2007; 21:3450-7
43. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 1994; 28:1176-9
44. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y: Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994; 267:H1948-54